The differential expression profile of pivotal signaling pathways and molecules, including estrogen receptor (ER), progesterone receptor (PR), and HER2, plays important roles in cancer biological behaviors, affects the choices of therapeutic intervention, and is associated with clinical outcomes [47, 48]. This evidence concerns the gene PGR and cancer.